Suhag A, Berghella V. Intrauterine Growth Restriction (IUGR): etiology and diagnosis. Curr Obstet Gynecol Rep. 2013;2:102–11.
Figueras F, Gardosi J. Intrauterine growth restriction: new concepts in antenatal surveillance, diagnosis, and management. Am J Obstet Gynecol (AJOG). 2011;204:288–300.
Myatt L, Eis AL, Brockman DE, Greer IA, Lyall F. Endothelial nitric oxide synthase in placental villous tissue from normal, pre-eclamptic and intrauterine growth restricted pregnancies. Hum Reprod. 1997;12:167–72.
Diaz V, Lebras-Isabet MN, Denjean A. Effect of Nomega-nitro-L-arginine methyl ester-induced intrauterine growth restriction on postnatal lung growth in rats. Pediatr Res. 2005;58:557–61.
Morris N, Eaton BM. Nitric oxide, the endothelium, pregnancy and pre-eclampsia. Br J Obstet Gynaecol. 1996;103:4–15.
Becker RM, Wu G, Galanko JA, Chen WN, Maynor AR, Bose CL, et al. Reduced serum amino acid concentrations in infants with necrotizing enterocolitis. J Pediatr. 2000;137:785–93.
Casanello P, Sobrevia L. Intrauterine growth retardation is associated with reduced activity and expression of the cationic amino acid transport systems yþ/hCAT-1 and yþ/hCAT-2B and lower activity of nitric oxide synthase in human umbilical vein endothelial cells. Circ Res. 2002;91:127–34.
Xiao XM, Li LM. L-Arginine treatment for asymmetric fetal growth restriction. Int J Gynecol Obstet. 2005;88:15–8.
Dera A, Ropacka M, Kowalska J, Markwitz W, Nycz P, Breborowicz GH. The effect of L-arginine treatment on the neonatal outcome from pregnancies complicated by intrauterine growth restriction and gestational hypertension. Arch Perinat Med. 2007;13:35–9.
Winer N, Branger B, Azria E, Tsatsaris V, Philippe HJ, Roze JC, et al. L-Arginine treatment for severe vascular fetal intrauterine growth restriction: a randomized double-bind controlled trial. Clin Nutr. 2009;28:243–8.
Zhang N, Xiong AH, Xiao X, Li LP. Effect and mechanism of L-arginine therapy for fetal growth retardation due to pregnancy-induced hypertension. J South Med Univ. 2007;27:198–200.
Ropacka M, Kowalska J, Hepner KB, Markwitz W, Breborowicz GH. The effect of L-arginine on fetal outcome in IUGR fetuses. Arch Perinat Med. 2007;13:30–4.
Shen SF, Hua CH. Effect of L-arginine on the expression of Bcl-2 and Bax in the placenta of fetal growth restriction. J Matern Fetal Neonatal Med. 2011;24:822–6.
Sieroszewski P, Suzin J, Bilińska AK. Utrasound evaluation of intrauterine growth restriction therapy by a nitric oxide donor (L-arginine). J Matern Fetal Neonatal Med. 2004;15:363–6.
Rytlewski K, Olszanecki R, Lauterbach R, Grzyb A, Basta A. Effects of oral L-Arginine on the foetal condition and neonatal outcome in preeclampsia. BCPT. 2006;99:146–52.
Singh S, Singh A, Sharma D, Singh A, Narula MK, Bhattacharjee J. Effect of l-arginine on nitric oxide levels in intrauterine growth restriction and its correlation with fetal outcome. Indian J Clin Biochem. 2015;30:298–304.
Dastjerdi MV, Hosseini S, Bayani L. Sildenafil citrate and uteroplacental perfusion in fetal growth restriction. J Res Med Sci. 2012;17:632–6.
von Dadelszen P, Dwinnell S, Magee LA, Carleton BC, Gruslin A, Lee B, et al. Sildenafil citrate therapy for severe early-onset intrauterine growth restriction. BJOG. 2011;118:624–8.
Gui SF, Jia J, Niu XY, Bai X, Zou H, Deng J, et al. Arginine supplementation for improving maternal and neonatal outcomes in hypertensive disorder of pregnancy: a systematic review. J Renin Angiotensin Aldosterone Syst. 2014;15:88–96.
Vadillo-Ortega F, Perichart-Perera O, Espino S, Marco AV, Isabel I, Roberto A, et al. Effect of supplementation during pregnancy with L-arginine and antioxidant vitamins in medical food on pre-eclampsia in high risk population: randomised controlled trial. BMJ. 2011;342:d2901.
Benedtto C, Marozio L, Neri I, Giarola M, Vlope A, Facchinetti F. Increased l-citrulline/l-arginine plasma ratio in severe preeclampsia. Obstet Gynecol. 2000;96:395–9.
Bode-Böger SM, Scalera F, Ignarro LJ. The L-arginine paradox: importance of the L-arginine/asymmetrical dimethylarginine ratio. Pharmacol Ther. 2007;114:295–306.
Neri I, Mazza V, Galassi MC, Volpe A, Facchinetti F. Effects of L-arginine on utero-placental circulation in growth-retarded fetuses. Acta Obstet Gynecol Scand. 1996;75:208–12.
Facchinetti F, Longo M, Piccinini F, Neri I, Volpe A. L-arginine infusion reduces blood pressure in preeclamptic women through nitric oxide release. J Soc Gynecol Investig. 1999;6:202–7.
Wu G, Bazer FW, Cudd TA, Jobgen WS, Kim SW, Lassala A, et al. Pharmacokinetics and safety of arginine supplementation in animals. J Nutr. 2007;137:1673S–80.
Curis E, Nicolis I, Moinard C, Osowska S, Zerrouk N, Be´nazeth S. Almost all about citrulline in mammals. Amino Acids. 2005;29:177–205.
Staff AC, Berge L, Haugen G, Lorentzen B, Mikkelsen B, Henriksen T. Dietary supplementation with L-arginine or placebo in women with pre-eclampsia. Acta Obstet Gynecol Scand. 2004;83:103–7.
Germain AM, Valdez G, Romanik MC, Reyes S. Letter to the editor: evidence supporting a beneficial role for long term L-arginine supplementation in high-risk pregnancies. Hypertension. 2004;44:e1.
Grimble GK. Adverse gastrointestinal effects of arginine and related amino acids. J Nutr. 2007;137:1693S–701.
Hladunewich MA, Derby GC, Lafayette RA, Blouch KL, Druzin ML, Myers BD. Effect of L-arginine therapy on the glomerular injury of preeclampsia: a randomized controlled trial. Obstet Gynecol. 2006;107:886–95.
Wu G, Bazer FW, Davis TA, Kim SW, Li P, Marc Rhoads J, et al. Arginine metabolism and nutrition in growth, health and disease. Amino Acids. 2009;37:153–68.
Lacassie HJ, Germain AM, Valdés G, Fernández MS, Allamand F, López H. Management of Eisenmenger syndrome in pregnancy with sildenafil and L-arginine. Obstet Gynecol. 2004;103:1118–20.
Kim SW, Wu G. Dietary arginine supplementation enhances the growth of milk-fed young pigs. J Nutr. 2004;134:625–30.
de Boo HA, Eremia SC, Bloomfield FH, Oliver MH, Harding JE. Treatment of intrauterine growth restriction with maternal growth hormone supplementation in sheep. Am J Obstet Gynecol (AJOG). 2008;199:559. e1–e9.
Kwon H, Wu G, Bazer FW, Spencer TE. Developmental changes in polyamine levels and synthesis in the ovine conceptus. Biol Reprod. 2003;69:1626–34.
Sher G, Fisch JD. Vaginal sildenafil (Viagra): a preliminary report of a novel method to improve uterine artery blood flow and endometrial development in patients undergoing IVF. Hum Reprod. 2000;15:806–9.
Wareing M, Myers JE, O’Hara M, Baker PN. Sildenafil citrate (Viagra) enhances vasodilatation in fetal growth restriction. J Clin Endocrinol Metab. 2005;90:2550–5.
Belik J. Sildenafil administration during pregnancy increases fetal rat weight gain. FASEB J. 2005;19:A1248.
Refuerzo JS, Sokol RJ, Aranda JV, Hallak M, Hotra JW, Kruger M, et al. Sildenafil citrate and fetal outcome in pregnant rats. Fetal Diagn Ther. 2006;21:259–63.
Paulus WE, Strehler E, Zhang M, Jelinkova L, El-Danasouri I, Sterzik K. Benefit of vaginal sildenafil citrate in assisted reproduction therapy. Fertil Steril. 2002;77:846–7.
Samangaya RA, Mires G, Shennan A, Skillern L, Howe D, McLeod A, et al. A randomised, double-blinded, placebo-controlled study of the phosphodiesterase type 5 inhibitor sildenafil for the treatment of preeclampsia. Hypertens Pregnancy. 2009;28:369–82.